SUPN Historical Earnings image   This SUPN historical earnings page last updated 5/11/2022
SUPN Historical Revenue
PeriodHistorical Earnings DateGAAP
Q1 20225/9/20220.15B
Q4 20214/13/20220.16B
Q3 202111/3/20210.15B
Q2 20218/4/20210.14B
Q1 20215/5/20210.13B
Q4 20202/25/20210.14B
Q3 202011/3/20200.16B
Q2 20208/18/20200.13B
Q1 20205/5/20200.09B
Q4 20192/25/20200.10B
Q3 201911/5/20190.10B
Q2 20198/6/20190.10B
Q1 20195/7/20190.09B
Q4 20182/26/2019115.93M
Q3 201811/6/2018103.00M
Q2 20188/7/201899.54M
Q1 20185/8/201890.43M
Q4 20172/27/201888.44M
Q3 201711/6/201780.40M
Q2 20178/2/201775.83M
Q1 20175/9/201757.58M
Q4 20162/28/201762.37M
Q3 20161/20/201756.80M
Q2 20168/2/201650.42M
Q1 20165/3/201643.08M
Q4 20153/2/201642.66M
Q3 201511/3/201538.59M
Q2 20158/4/201535.05M
Q1 20155/5/201528.13M
Q4 20143/10/201530.08M
Q3 201411/11/201452.50M
Q2 20148/11/201427.60M
Q1 20145/5/20149.08M
Q4 20133/12/201410.30M
Q3 201311/12/20131.26M
Q2 20138/13/2013281000
Q1 20135/13/2013147000
Q4 20123/14/2013109000
SUPN Historical Earnings EPS
Data adjusted for SUPN split history

PeriodHistorical Earnings DateGAAP
Q1 20225/9/20220.430
Q4 20214/13/20220.040
Q3 202111/3/20210.400
Q2 20218/4/20210.430
Q1 20215/5/20210.110
Q4 20202/25/20210.570
Q3 202011/3/20200.740
Q2 20208/18/20200.650
Q1 20205/5/20200.400
Q4 20192/25/20200.620
Q3 201911/5/20190.540
Q2 20198/6/20190.610
Q1 20195/7/20190.340
Q4 20182/26/20190.48
Q3 201811/6/20180.52
Q2 20188/7/20180.57
Q1 20185/8/20180.49
Q4 20172/27/20180.44
Q3 201711/6/20170.29
Q2 20178/2/20170.32
Q1 20175/9/20170.19
Q4 20162/28/20170.26
Q3 20161/20/20170.37
Q2 20168/2/20160.18
Q1 20165/3/20160.08
Q4 20153/2/20160.14
Q3 201511/3/20150.08
Q2 20158/4/20150.03
Q1 20155/5/20150.02
Q4 20143/10/20150.08
Q3 201411/11/20140.39
Q2 20148/11/20140.08
Q1 20145/5/2014-0.38
Q4 20133/12/2014-0.65
Q3 201311/12/2013-0.78
Q2 20138/13/2013-0.89
Q1 20135/13/2013-0.6
Q4 20123/14/2013-0.51
Quotes delayed 20 minutes

Email EnvelopeFree SUPN Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Supernus Pharmaceuticals (SUPN) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

SURF Past Earnings
SVRA Past Earnings
SWAV Past Earnings
SWTX Past Earnings
SYBX Past Earnings
SYK Past Earnings
SYNH Past Earnings
SYRS Past Earnings
TALS Past Earnings
TARA Past Earnings
What was the record high SUPN historical earnings result?
In terms of earnings or revenue, what is the best SUPN historical earnings result that Supernus Pharmaceuticals has ever posted, and when?

✔️Accepted answer: Within our data set, the highest SUPN historical earnings result was set in Q3 2020, when Supernus Pharmaceuticals posted results of 0.740/share. The most successful revenue quarter within our data set was Q4 2021 when Supernus Pharmaceuticals reported revenue of 0.16B.

What was the lowest Supernus Pharmaceuticals historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest SUPN has reported, and when?

✔️Accepted answer: Within our data set, the lowest SUPN historical earnings result was set in Q2 2013, when Supernus Pharmaceuticals posted results of -0.89/share. The smallest revenue quarter within our data set was Q4 2012 when Supernus Pharmaceuticals reported revenue of 109000.

On this page we presented the SUPN historical earnings date information for Supernus Pharmaceuticals. Reviewing that SUPN Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q3 2020, when SUPN posted gaap of 0.740/share. Meanwhile the lowest SUPN historical earnings result was in Q2 2013, when SUPN posted gaap of -0.89/share. Moving to Supernus Pharmaceuticalss historical revenue numbers, the largest revenue quarter in our data set was seen in Q4 2021 when SUPN reported 0.16B in revenue, while the smallest revenue quarter was Q4 2012 when SUPN reported 109000 in revenue.

For self directed investors doing their due diligence on SUPN or any other given stock, their research can benefit from looking into all of the Supernus Pharmaceuticals historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into Supernus Pharmaceuticals historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for SUPN. Thanks for visiting, and the next time you need to research SUPN historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: Institutional Holders of CARB, HPJ Options Chain, SFE YTD Return.

 

SUPN Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.